Maxcyte, Inc.
MXCT· Nasdaq
Released Sep 13, 2021, after the close
10-Q filed Sep 13, 2021, 75 days after period end · 0001558370-21-012432
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Net Income | -$4.42M | -$3.00M |
| EPS Diluted | -$0.05 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Maxcyte, Inc. · CIK 1287098 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Sep 13, 2021 · 75 d after period end
+0.7% from the close of Sep 13, 2021 to the close of Sep 14, 2021, the first after the release.